Skip to content
Home/Companies/Biotech/General Biotechnologies

General Biotechnologies

Biotech·UK·Active·New
Entry
2026
Hold
New
Status
Active

Who owns General Biotechnologies?

General Biotechnologies is currently owned by Kompas Vc through Kompas Fund II (2025 vintage), since 2026.

Hand-verified · updated 2026-08-18

Kompas Vc
Investor
Kompas Vc
Kompas Fund II · 2025 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Kompas Fund II

Other portfolio companies in the same fund.

Array Labs
Array Labs
Active
Aerospace & DefenceUS· 2026
AZX
Active
AI/MLUS· 2026
Backslash
Active
CybersecurityIsrael· 2026
Epoch Biodesign
Active
ClimateTechUK· 2026
Timefold
Timefold
Active
SaaSBelgium· 2026
United Manufacturing Hub
Active
IndustrialsGermany· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track General Biotechnologies

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy General Biotechnologies?

4 strategic and 116financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on General Biotechnologies.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue